Clinical Trials in Arizona

Showing 15341-15360 of 16,770 trials

Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors

NCT01014429

The purpose of this study is to evaluate the safety and tolerability of NMS-1286937, a polo-like-kinase 1 inhibitor, in patients with advanced metastatic solid tumor.

Advanced or Metastatic Solid Tumors

Nerviano Medical Sciences21 participantsStarted Nov 2009

Scottsdale, Arizona, United States

COMPLETEDPhase 331 miles

Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee

NCT00313846

The objective of this study is to demonstrate the effectiveness and tolerability of the buprenorphine transdermal system (BTDS) (5, 10 and 20) in comparison to placebo transdermal system in subjects with moderate to severe osteoarthritis pain of the hip and knee currently treated with oral opioids. The double-blind treatment intervention duration is 4 weeks during which time supplemental analgesic medication (acetaminophen) will be provided to all subjects in addition to study drug.

Osteoarthritis

Purdue Pharma LP529 participantsStarted Apr 2003

Mesa, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +41 more locations

Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors

Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee

Find Trials by Condition in Arizona

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain

Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA Pain

Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder

EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study

CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma

Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)

Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer

Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation

PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia

Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery